Janas, Maja M.
Schlegel, Mark K.
Harbison, Carole E.
Yilmaz, Vedat O.
Jiang, Yongfeng
Parmar, Rubina
Zlatev, Ivan http://orcid.org/0000-0003-2797-3032
Castoreno, Adam
Xu, Huilei
Shulga-Morskaya, Svetlana
Rajeev, Kallanthottathil G.
Manoharan, Muthiah
Keirstead, Natalie D.
Maier, Martin A.
Jadhav, Vasant
Article History
Received: 15 June 2017
Accepted: 11 January 2018
First Online: 19 February 2018
Competing interests
: All authors are employees of Alnylam Pharmaceuticals with salary and stock options. REVERSIR is a trademark of Alnylam Pharmaceuticals.